Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.

Is Saturday good for hiking near Denver? Activity-specific go/no-go rating (1-10) for hiking, skiing, surfing, cycling, camping, running, golf, beach, or fishing, with a gear checklist and alternative dates if conditions are bad.

Agent-tier preview of the $5 medical-bill letter: deterministic eligibility verdict, which rights/statutes apply, computed deadlines, and exactly what the full letter adds — no document drafted, no LLM. Honest-no on expired windows and unprotected scenarios.

Out-of-pocket cost calculator for healthcare and consumer-health agents. Returns the exact patient cost given deductible, coinsurance, and OOP max for any procedure and plan.

Citation-locked medical-bill letter: No Surprises Act balance-bill dispute, health-plan internal appeal, hospital financial-assistance cover letter, Medicare redetermination, or GFE dispute filing pack — deterministic eligibility + computed deadlines + a ready-to-send document. Honest-no: nothing sold on expired windows or unprotected scenarios.

What can I plant right now? Growing-season intelligence — USDA hardiness zone, last/first frost dates, and a planting calendar (what to plant now, start indoors, or plan for the next 4 weeks) with frost-protection and season-extension tips.

Rank 2-6 candidate dates for an outdoor event by real historical weather odds. Rain, heat, frost, wind, and extreme-heat probabilities counted in code from 10 years of NASA POWER reanalysis rows for each date, a deterministic 0-100 weather-favorability score, per-date risk verdicts, and a plain-language recommendation. The "which Saturday should we book?" call for weddings, festivals, and races — any location worldwide.

FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.

Premium event-weather brief for any date and location worldwide. Rain, heat, frost, wind, and extreme-heat odds computed in code from 10 years of actual NASA POWER reanalysis rows (counted, not model-estimated), the live 10-day MET Norway forecast when the date is in range, a dated go/no-go decision timeline, contingency plan, schedule guidance, and heat-safety plan for weddings, festivals, marathons, and any outdoor event.

Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.

Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.

Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.

Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.

Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For agents with small per-call budgets; upgrade to disease-landscape for approved drugs, mechanism gaps, PDUFA calendar, deal activity and an opportunity score.

Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.

Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.

Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.

Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals.

Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recalls, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents.

Is it real or fake? Collectible authentication & counterfeit check for autographs, memorabilia, watches, cards and art. Returns red flags for fakes, trusted authentication services, DIY verification checks, and how to buy safely for any collectible. Worldwide. For collector and investor agents.